Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karamjit Singh Dolt

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Brain Pathology (Zurich, Switzerland)|June 7, 2017
Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutationsKaramjit Singh Dolt, Fella Hammachi, Tilo Kunath
Current Topics in Developmental Biology|April 20, 2025
Understanding developing kidneys and Wilms tumors one cell at a timeNine Solee Pop, Karamjit Singh Dolt, Peter Hohenstein
Frontiers in Cell and Developmental Biology|November 23, 2020
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal DifferentiationNicola J Drummond, Karamjit Singh Dolt, Maurice A Canham, et al.
Plos One|May 3, 2013
A universal vector for high-efficiency multi-fragment recombineering of BACs and knock-in constructsKaramjit Singh Dolt, Melanie L Lawrence, Eve Miller-Hodges, et al.
Brain Communications|June 27, 2025
Glycine-to-aspartic acid mutation at codon 51 in <i>Snca</i> disrupts the synaptic localisation of α-synuclein and enhances its propensity for synucleinopathyStephen West, Ammar Natalwala, Karamjit Singh Dolt, et al.
Transgenic Research|July 9, 2024
Redundancy of p75NTR neurotrophin receptor function in development, growth and fertility in the ratStephen Meek, Karamjit Singh-Dolt, Linda Sutherland, et al.
Journal of Neuroscience Research|January 10, 2008
YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatmentIshwar Dutt Vats, Karamjit Singh Dolt, Krishan Kumar, et al.
Frontiers in Neuroscience|June 9, 2023
Victoria Morley, Karamjit Singh Dolt, Carlos J Alcaide-Corral, et al.
The European Journal of Neuroscience|November 26, 2018
Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA geneYixi Chen, Karamjit Singh Dolt, Marco Kriek, et al.
NPJ Parkinson'S Disease|April 20, 2025
A high-fidelity microfluidic platform reveals retrograde propagation as the main mechanism of α-Synuclein spread in human neuronsRozan Vroman, Lorenzo de Lichtervelde, Karamjit Singh Dolt, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Brain Pathology (Zurich, Switzerland)|June 7, 2017
Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutationsKaramjit Singh Dolt, Fella Hammachi, Tilo Kunath
Current Topics in Developmental Biology|April 20, 2025
Understanding developing kidneys and Wilms tumors one cell at a timeNine Solee Pop, Karamjit Singh Dolt, Peter Hohenstein
Frontiers in Cell and Developmental Biology|November 23, 2020
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal DifferentiationNicola J Drummond, Karamjit Singh Dolt, Maurice A Canham, et al.
Plos One|May 3, 2013
A universal vector for high-efficiency multi-fragment recombineering of BACs and knock-in constructsKaramjit Singh Dolt, Melanie L Lawrence, Eve Miller-Hodges, et al.
Brain Communications|June 27, 2025
Glycine-to-aspartic acid mutation at codon 51 in <i>Snca</i> disrupts the synaptic localisation of α-synuclein and enhances its propensity for synucleinopathyStephen West, Ammar Natalwala, Karamjit Singh Dolt, et al.
Transgenic Research|July 9, 2024
Redundancy of p75NTR neurotrophin receptor function in development, growth and fertility in the ratStephen Meek, Karamjit Singh-Dolt, Linda Sutherland, et al.
Journal of Neuroscience Research|January 10, 2008
YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatmentIshwar Dutt Vats, Karamjit Singh Dolt, Krishan Kumar, et al.
Frontiers in Neuroscience|June 9, 2023
Victoria Morley, Karamjit Singh Dolt, Carlos J Alcaide-Corral, et al.
The European Journal of Neuroscience|November 26, 2018
Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA geneYixi Chen, Karamjit Singh Dolt, Marco Kriek, et al.
NPJ Parkinson'S Disease|April 20, 2025
A high-fidelity microfluidic platform reveals retrograde propagation as the main mechanism of α-Synuclein spread in human neuronsRozan Vroman, Lorenzo de Lichtervelde, Karamjit Singh Dolt, et al.
Pageof 2